Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9X47
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,057
Award facts
- Contract value 100% obligated
- $43,057.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $43,057.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections on January 14, 2026, with completion targeted for January 15, 2026. This is a non-set-aside contract, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where the prime contractor maintains its corporate headquarters. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving the Defense Health Agency and military healthcare systems.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs worldwide. The current order for Zepbound—a GLP-1 receptor agonist indicated for weight management—represents one of numerous task orders fulfilling the broad medical supply needs of the Defense Health System and other federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F9X47?
SPE2DR26F9X47 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26F9X47 worth?
The government has obligated $43,057 on SPE2DR26F9X47.
Is contract SPE2DR26F9X47 an order under another contract?
Yes. SPE2DR26F9X47 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9X47 competed?
The extent of competition for SPE2DR26F9X47 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award